Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEMS 3 pilot trial of filgrastim and rehabilitation therapy in chronic stroke
2011-001684-50Phase 2Completed
- Sponsor
- University of Nottingham
- Start
- Apr 2011
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of filgrastim in stroke (4 arms), sponsored by University of Nottingham. Primary endpoints: Feasibility of drug administration, Feasibility of rehabilitation delivery and 3 more. Started Apr 2011; status: completed.
02
Drugs
filgrastim
03
Conditions
stroke
Beyond the preview
Go deeper on 2011-001684-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001684-50.